FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

9155911000001100: Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1899581000001110 Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1899591000001112 Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Is a Clarithromycin 125mg/5ml oral suspension 70 ml true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Is pack of Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Has active ingredient Clarithromycin false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Has AMP Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Has specific active ingredient Clarithromycin true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Clarithromycin 125mg/5ml oral suspension (Kent Pharma (UK) Ltd) 70 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start